NRCME Hypertension Guidelines 5 — Questions and Answers
Question 1: A long-haul driver self-reports excellent BP control on medication but presents without documentation. What should the CME do?
- Measure BP at the examination and base certification on the observed reading and clinical findings (Correct answer)
- Accept the driver's report and issue a 2-year certificate
- Disqualify for lack of documentation
- Call the driver's pharmacy to verify
Correct answer: Measure BP at the examination and base certification on the observed reading and clinical findings
The CME's physical examination and direct BP measurement are the primary basis for certification decisions; self-report alone is insufficient without objective clinical data.
Question 2: A driver with hypertension also has a history of stroke. Which aspect of the stroke history is most critical for FMCSA fitness determination?
- Residual neurological deficits, cognitive impairment, or functional limitations affecting driving (Correct answer)
- Whether the stroke was ischemic or hemorrhagic
- The driver's age at the time of stroke
- The total cholesterol level at the time of stroke
Correct answer: Residual neurological deficits, cognitive impairment, or functional limitations affecting driving
Residual neurological deficits such as hemiparesis, visual field loss, or cognitive impairment directly affect the driver's ability to safely operate a commercial vehicle and are the CME's primary concern.
Question 3: Which measurement technique error is most likely to falsely elevate a driver's blood pressure reading during a CME exam?
- Using a cuff that is too small for the arm circumference (Correct answer)
- Taking the reading immediately after the driver sits down
- Measuring on the non-dominant arm
- Using an aneroid sphygmomanometer instead of a mercury device
Correct answer: Using a cuff that is too small for the arm circumference
A cuff that is too small for the arm will artificially elevate the BP reading, potentially leading to inappropriate disqualification or shortened certification.
Question 4: Why is isolated systolic hypertension (e.g., 165/78 mmHg) clinically important in the context of FMCSA evaluations?
- Elevated systolic BP increases cardiovascular risk and must be staged and managed like combined hypertension (Correct answer)
- Isolated systolic elevations are ignored if diastolic is normal
- Only diastolic BP matters for FMCSA purposes
- Isolated systolic hypertension is disqualifying regardless of treatment
Correct answer: Elevated systolic BP increases cardiovascular risk and must be staged and managed like combined hypertension
Isolated systolic hypertension carries significant cardiovascular risk, particularly for stroke, and is staged and managed under the same FMCSA thresholds as combined hypertension.
Question 5: A CME is seeing a 62-year-old driver with BP of 148/88 mmHg and no prior hypertension diagnosis. The driver mentions he had coffee and rushed to the appointment. The best next step is:
- Have the driver rest for at least 5 minutes and remeasure BP before making a determination (Correct answer)
- Immediately classify as Stage 1 and issue a 12-month certificate
- Disqualify pending full cardiac workup
- Issue a 2-year certificate since the reading is not Stage 2
Correct answer: Have the driver rest for at least 5 minutes and remeasure BP before making a determination
Factors such as recent caffeine intake and physical exertion can transiently elevate BP; resting and remeasuring ensures an accurate baseline reading for certification decisions.
Question 6: Which of the following best explains why the FMCSA requires annual recertification for Stage 1 hypertensive drivers rather than the standard 2-year interval?
- To monitor for disease progression, medication adherence, and development of target-organ damage (Correct answer)
- To increase revenue for medical examiners
- Because Stage 1 drivers are automatically disqualified after one year
- To comply with state motor vehicle licensing requirements
Correct answer: To monitor for disease progression, medication adherence, and development of target-organ damage
Annual recertification for Stage 1 hypertensive drivers allows the CME to detect worsening hypertension, medication side effects, or new target-organ damage before the driver's risk escalates.
Question 7: A driver on combination antihypertensive therapy (ACE inhibitor + diuretic) presents with a BP of 128/78 mmHg and no side effects. The CME should:
- Certify for up to 2 years if no other disqualifying conditions are found (Correct answer)
- Certify for only 6 months because of combination therapy
- Require the driver to reduce to one medication before certifying
- Disqualify because the driver is on two medications
Correct answer: Certify for up to 2 years if no other disqualifying conditions are found
Well-controlled BP with no disqualifying side effects qualifies the driver for standard 2-year certification regardless of how many antihypertensive agents are used.
NRCME Hypertension Guidelines 5
A long-haul driver self-reports excellent BP control on medication but presents without documentation.
What should the CME do?